GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: R-95867 | R95867
Compound class:
Synthetic organic
Comment: Tacapenem (R-95867) is a β-lactam class antibacterial. It exhibits broad-spectrum antibacterial activity and it is highly stable to β-lactamases. An ester-type prodrug of R-95867, CS-834 (tacapenem pivoxil for oral administration), has been described [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8235 | tacapenem |
Synonyms ![]() |
| R-95867 | R95867 |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Tacapenem |
| Other databases | |
| CAS Registry No. | 193811-33-5 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL3989499 |
| GtoPdb PubChem SID | 405560304 |
| PubChem CID | 73302 |
| Search Google for chemical match using the InChIKey | CTEFNVKDRWMZSL-CTNSIQBBSA-N |
| Search Google for chemicals with the same backbone | CTEFNVKDRWMZSL |
| Search PubMed clinical trials | tacapenem |
| Search PubMed titles | tacapenem |
| Search PubMed titles/abstracts | tacapenem |
| UniChem Compound Search for chemical match using the InChIKey | CTEFNVKDRWMZSL-CTNSIQBBSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | CTEFNVKDRWMZSL-CTNSIQBBSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖